Gregory A. Brower is a Shareholder with Brownstein Hyatt Farber Schreck, LLP in Las Vegas, NV and Washington, DC. Mr. Brower also serves on WLF Legal Policy Advisory Board and is the WLF Legal Pulse’s Featured Expert Contributor, White Collar Crime and Corporate Compliance.

In a bold defense of fundamental fairness in the context of a criminal prosecution, a federal district court judge in Massachusetts recently granted a motion to vacate the convictions of two defendants who argued that the Food and Drug Administration’s (“FDA”) regulatory authority over compounding pharmacies was not clearly established, and thus their convictions for conspiring to defraud the FDA were legally impossible and violated basic norms of due process.